Rationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: The PREVENT-HD study

作者：Warren H. Capell, Elliot S. Barnathan, Gregory Piazza, Alex C. Spyropoulos, Judith Hsia, Scott Bull, Concetta Lipardi, Chiara Sugarmann, Eunyoung Suh, Jaya Prakash Rao, William R. Hiatt, Marc P. Bonaca · 发表于：American Heart Journal · 年份：2021 · DOI：10.1016/j.ahj.2021.02.001 · 被引用次数：44 · 研究领域：COVID-19 Clinical Research Studies、Venous Thromboembolism Diagnosis and Management、Heparin-Induced Thrombocytopenia and Thrombosis